Stockscreener 앱 받기
5.195
0.87%
0.035
Abeona Therapeutics Inc 주식(ABEO)의 최신 뉴스
Will Abeona Therapeutics Inc. (PCJ) stock draw ESG focused funds2026 world cup usa national team round of 32 defensive leaders counter attacking knockout prediction guide - Улправда
Trading Systems Reacting to (ABEO) Volatility - Stock Traders Daily
3 Insider-Owned Growth Stocks For Your Watchlist - simplywall.st
Abeona Therapeutics announces employee inducement grants - MSN
Abeona Therapeutics (ABEO) Issues Equity Awards to New Staff - GuruFocus
Abeona Therapeutics® announces new employee inducement grants under Nasdaq Listing Rule 5635(c)(4) - marketscreener.com
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(C)(4) - TradingView — Track All Markets
Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - 富途牛牛
Abeona Therapeutics Inc. (NASDAQ:ABEO) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Insider Sell: Vishwas Seshadri Sells 25,000 Shares of Abeona The - GuruFocus
Abeona Therapeutics (NASDAQ:ABEO) CEO Vishwas Seshadri Sells 25,000 Shares - MarketBeat
Avoiding Lag: Real-Time Signals in (ABEO) Movement - Stock Traders Daily
Is Abeona Therapeutics Inc. stock dividend yield sustainableEarnings Growth Summary & Risk Adjusted Buy/Sell Alerts - Улправда
Short Covering: Why institutional investors increase stakes in Abeona Therapeutics Inc. (PCJ) stockM&A Rumor & Weekly High Momentum Picks - Улправда
How Abeona Therapeutics Inc. stock performs in stagflation2025 Geopolitical Influence & Weekly Watchlist for Hot Stocks - Улправда
How Abeona Therapeutics Inc. stock performs in high volatility markets2025 Valuation Update & Precise Trade Entry Recommendations - Улправда
Why Abeona Therapeutics Inc. stock remains a top recommendationPortfolio Update Report & Verified Short-Term Plans - DonanımHaber
Can Abeona Therapeutics Inc. stock reach $100 price targetPortfolio Growth Summary & Low Risk High Win Rate Picks - ulpravda.ru
How Abeona Therapeutics Inc. stock reacts to global recession fearsTrade Entry Report & Real-Time Price Movement Reports - ulpravda.ru
Abeona Therapeutics appoints Mohamad Tabrizi as chief business officer By Investing.com - Investing.com Nigeria
Abeona Therapeutics appoints Mohamad Tabrizi as chief business officer - Investing.com
Abeona Therapeutics names Mohamad Tabrizi as chief business officer - marketscreener.com
Abeona Therapeutics Appoints Mohamad Tabrizi as Senior Vice President, Chief Business Officer - Quiver Quantitative
Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer - marketscreener.com
(ABEO) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
Quarterly Earnings: Will Abeona Therapeutics Inc stock benefit from M A activityJuly 2025 Sector Moves & Safe Capital Growth Tips - moha.gov.vn
AWM Investment Company Inc. Acquires New Shares in Abeona Therapeutics Inc. $ABEO - MarketBeat
Boone Capital Management LLC Makes New Investment in Abeona Therapeutics Inc. $ABEO - MarketBeat
Abeona Therapeutics (NASDAQ:ABEO) Share Price Passes Below Two Hundred Day Moving AverageTime to Sell? - MarketBeat
Abeona Therapeutics (ABEO) Expands Zevaskyn Treatment Access in Texas - GuruFocus
Abeona Therapeutics Activates New Qualified Treatment Center for ZEVASKYN in Texas - Quiver Quantitative
Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas - GlobeNewswire
University of Texas Medical Branch activated as treatment center for RDEB therapy - Investing.com
Is Abeona Therapeutics Inc a good long term investment - earlytimes.in
Abeona Therapeutics (ABEO) Begins First Commercial Use of ZEVASK - GuruFocus
Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy - The Manila Times
Abeona Therapeutics Announces First Commercial Patient Treatment with FDA-Approved ZEVASKYN for Recessive Dystrophic Epidermolysis Bullosa - Quiver Quantitative
Abeona Therapeutics (Nasdaq: ABEO) begins commercial use of FDA-approved ZEVASKYN for RDEB - Stock Titan
Is Abeona Therapeutics Stock Built to Withstand a Pullback? - Trefis
Abeona Therapeutics Inc. (NASDAQ:ABEO) Receives Consensus Rating of "Moderate Buy" from Analysts - MarketBeat
What makes Abeona Therapeutics Inc. stock attractive to growth funds2025 Performance Recap & Reliable Intraday Trade Plans - Newser
Will Abeona Therapeutics Inc. stock see PE expansionSell Signal & Free Weekly Chart Analysis and Trade Guides - Newser
Can Abeona Therapeutics Inc. (PCJ) stock survive global slowdownJuly 2025 Institutional & Verified Trade Idea Suggestions - Newser
How forex fluctuations impact Abeona Therapeutics Inc. (PCJ) stockMarket Growth Summary & Expert Curated Trade Ideas - Newser
How strong is Abeona Therapeutics Inc. stock balance sheetVolume Spike & Community Trade Idea Sharing - Newser
Abeona Therapeutics (ABEO) Stock Analysis Report | Financials & Insights - Benzinga
Why retail traders accumulate Abeona Therapeutics Inc. (PCJ) stockMarket Sentiment Summary & AI Optimized Trading Strategy Guides - Newser
Can Abeona Therapeutics Inc. (PCJ) stock sustain revenue momentumJuly 2025 WrapUp & Real-Time Volume Trigger Notifications - Newser
What downside risks could hit Abeona Therapeutics Inc. (PCJ) stockPortfolio Gains Summary & Technical Confirmation Trade Alerts - Newser
Published on: 2025-12-02 01:12:50 - Newser
Abeona Therapeutics (ABEO) Distributes Equity Awards to New Empl - GuruFocus
Abeona announces employee inducement grants under Nasdaq rule - marketscreener.com
ABEO FY2025 EPS Forecast Lifted by Cantor Fitzgerald - MarketBeat
Why institutional investors increase stakes in Abeona Therapeutics Inc. (PCJ) stock2025 Top Gainers & Precise Entry and Exit Recommendations - BỘ NỘI VỤ
1.38%
자본화:
|
볼륨(24시간):